Work

Abstract 411: Selective degradation of SMARCA2 and dual degradation of SMARCA2 and SMARCA4 has strong antitumor activity in marginal zone lymphoma (MZL)

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-411

Authors: Alberto J. Arribas, Eleonora Cannas, Stefano Pileri, Davide Rossi, Diane Heiser, Francesco Bertoni

Institutions: Institute of Oncology Research, European Institute of Oncology, Prelude Therapeutics Incorporated (United States)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409689517

Cites:

Cited by:

Related to: 10